Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables and Cerebrovascular Reactivity in Patients With Recent Stroke or TIA.

Trial Profile

Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables and Cerebrovascular Reactivity in Patients With Recent Stroke or TIA.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2014

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Stroke; Transient ischaemic attacks
  • Focus Adverse reactions
  • Sponsors Orion
  • Most Recent Events

    • 01 Apr 2014 New trial record
    • 24 Nov 2009
    • 28 Oct 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top